Welcome to LookChem.com Sign In|Join Free

CAS

  • or

937244-10-5

Post Buying Request

937244-10-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

937244-10-5 Usage

Uses

Different sources of media describe the Uses of 937244-10-5 differently. You can refer to the following data:
1. N-Boc-cis-3,4-Methylene D-Proline is used in the pyrrolidine carboxamides preparation and SAR as 11β-HSD1 inhibitors.
2. Used in the pyrrolidine carboxamides preparation and SAR as 11β-HSD1 inhibitors.

Check Digit Verification of cas no

The CAS Registry Mumber 937244-10-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,3,7,2,4 and 4 respectively; the second part has 2 digits, 1 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 937244-10:
(8*9)+(7*3)+(6*7)+(5*2)+(4*4)+(3*4)+(2*1)+(1*0)=175
175 % 10 = 5
So 937244-10-5 is a valid CAS Registry Number.

937244-10-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name (1R,2R,5R)-3-{[(2-Methyl-2-propanyl)oxy]carbonyl}-3-azabicyclo[3. 1.0]hexane-2-carboxylic acid

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:937244-10-5 SDS

937244-10-5Downstream Products

937244-10-5Relevant articles and documents

IMMUNOPROTEASOME INHIBITORS

-

, (2018/08/20)

Provided herein are compounds, such as a compound of Formula (I), as described herein, or a pharmaceutically acceptable salt thereof, that are immunoproteasome (such as LMP2 and LMP7) inhibitors. The compounds described herein can be useful for the treatment of diseases treatable by inhibition of immunoproteasomes. Also provided herein are pharmaceutical compositions containing such compounds and processes for preparing such compounds.

Synthesis of all four stereoisomers of 3-(tert-butoxycarbonyl)-3- azabicyclo[3.1.0]hexane-2-carboxylic acid

Bakonyi, Bettina,Furegati, Markus,Kramer, Christian,La Vecchia, Luigi,Ossola, Flavio

, p. 9328 - 9339 (2013/10/08)

A synthesis of all four stereoisomers of 3-(tert-butoxycarbonyl)-3- azabicyclo[3.1.0]hexane-2-carboxylic acid has been developed, thereby significantly shortening the known literature procedures for the syntheses of these unnatural amino acids. With a simple adjustment of the reaction conditions, we were able to obtain either pure cis or trans acid. Optical resolution was accomplished via diastereomeric salt formation or alternatively via chromatography on a chiral stationary phase. Finally, ab initio calculations gave an explanation for the observed cis selectivity in the initial step.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 937244-10-5